Last reviewed · How we verify
baclofen 2%
At a glance
| Generic name | baclofen 2% |
|---|---|
| Also known as | baclofen |
| Sponsor | Express Specialty Pharmacy |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Multiprofen-CC to Reduce Pain in Hand Arthritis (PHASE3)
- Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge (PHASE2)
- Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty (PHASE3)
- Intrathecal Baclofen and Pediatric Dystonia (NA)
- Baclofen Versus Gabapentin in Preventing Postoperative Pain After Laparoscopic Sleeve Gastrectomy (PHASE3)
- Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery (PHASE2, PHASE3)
- A Prospective Cohort Study of ITB Treatment for HSP
- Effects of Baclofen on Presynaptic Inhibition in Humans (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- baclofen 2% CI brief — competitive landscape report
- baclofen 2% updates RSS · CI watch RSS
- Express Specialty Pharmacy portfolio CI